Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services
Veterans Affairs, Department of · VETERANS AFFAIRS, DEPARTMENT OF
This notice is not accepting responses (deadline was Nov 12, 2025, 3:00 PM EST).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Nov 12, 2025, 3:00 PM EST
- Posted
- Nov 4, 2025
- Solicitation
- 36C25026Q0104
- Set-aside
- No Set aside used
- Place of performance
- Cleveland, OH, USA
- Contracting office
- 250-NETWORK CONTRACT OFFICE 10 (36C250) · DAYTON · OH
- Source
- SAM.gov · updated Jul 5, 2026
Description
Notice of Intent to Sole-Source Requirement: The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 621511, Size Standard is $41.5 Million. The Product Service Code (PSC) is Q301. The sole-source contract will be awarded to: ADAPTIVE BIOTECHNOLOGIES CORPORATION UEI: DMW5BNQ331K9 Description of requirements: The VA Northeast Ohio Healthcare System (VANEOHS), Pathology and Laboratory Medicine Service (PALMS), requires molecular minimal residual disease (MRD) testing services utilizing the clonoSEQ Assay provided exclusively by Adaptive Biotechnologies. The clonoSEQ Assay is a proprietary, patented molecular test developed and performed exclusively by Adaptive Biotechnologies. Adaptive Biotechnologies is the sole source provider of clonoSEQ MRD testing within the United States. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government. The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government. All responses to this intent to sole source must be emailed to Thomas Bellamy @ thomas.bellamy@va.gov by 3:00 p.m. EST November 12th, 2025.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$87,643
Middle of the pack for similar past awards
Most similar awards fall between $22,915 and $397,069
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1QUEST DIAGNOSTICS INCORPORATED548 awards$314.03M
- 2LABORATORY CORPORATION OF AMERICA139 awards$196.04M
- 3HELIX OPCO LLC1 award$81.89M
- 4LABORATORY CORPORATION OF AMERICA63 awards$71.43M
- 5FOUNDATION MEDICINE, INC.7 awards$71.34M
- 6ARUP LABORATORIES INC39 awards$19.83M
- 7OREGON HEALTH & SCIENCE UNIVERSITY8 awards$16.28M
- 8FULGENT THERAPEUTICS LLC4 awards$15.96M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID e20d8f5c834840859e63658c02d4d6f5.